Clinical Trial Update: A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability, and pharmacokinetics study of PGDM1400LS alone and in combination with VRC07-523LS and PGT121.414.LS in healthy HIV-uninfected adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• PGDM1400LS
• PGT121.414.LS
• VRC07-523LS

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2025-02-10